Novartis AG
XETRA:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novartis AG
XETRA:NOT
|
CH |
|
Canon Marketing Japan Inc
OTC:CAMJF
|
JP |
|
S
|
Salazar Resources Ltd
DUS:CCG
|
CA |
|
Home Product Center PCL
OTC:HPCRF
|
TH |
|
V
|
Vortex Energy Corp
NEO:VRTX
|
CA |
|
P
|
Pentair PLC
F:PNT
|
UK |
|
O
|
Organigram Global Inc
SWB:0OG
|
CA |
|
Recruit Holdings Co Ltd
F:1RH
|
JP |
|
Parrot SA
F:P2W
|
FR |
|
Mogotes Metals Inc
XTSX:MOG
|
CA |
|
A
|
AI/ML Innovations Inc
SWB:42FB
|
CA |
|
G
|
General Motors Co
XHAN:8GM
|
US |
|
S
|
Silex Systems Ltd
SWB:RW4
|
AU |
|
Weathernews Inc
OTC:WNWSF
|
JP |
|
C
|
Compagnie Financiere Richemont SA
XETRA:RITN
|
CH |
|
SLM Corp
NASDAQ:SLM
|
US |
|
S
|
Samyung ENC Co Ltd
KOSDAQ:065570
|
KR |
|
Samwha Electronics Co Ltd
KRX:011230
|
KR |
|
C
|
China Steel Corp
TWSE:2002
|
TW |
|
A
|
Adecco Group AG
XMUN:ADI1
|
CH |
|
F
|
FedEx Corp
DUS:FDX
|
US |
|
C
|
Canadian National Railway Co
XHAN:CY2
|
CA |
|
S
|
Sixt SE
XHAM:SIX3
|
DE |
|
Sonic Foundry Inc
OTC:SOFO
|
US |
Bankruptcy Probability
Novartis AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Novartis AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
|
Novartis AG
SIX:NOVN
|
249.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
662.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
390.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
361.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
202.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
257.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
170.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Novartis AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Novartis AG has total debt of 38.4B USD. This includes both short-term (0 USD) and long-term (38.4B USD) debt.
You can find a full breakdown on its Balance Sheet.